Development of an MCL-1-related prognostic signature and inhibitors screening for glioblastoma.
Zhang A, Guo Z, Ren JX, Chen H, Yang W, Zhou Y, Pan L, Chen Z, Ren F, Chen Y, Zhang M, Peng F, Chen W, Wang X, Zhang Z, Wu H.
Zhang A, et al. Among authors: pan l.
Front Pharmacol. 2023 Jul 19;14:1162540. doi: 10.3389/fphar.2023.1162540. eCollection 2023.
Front Pharmacol. 2023.
PMID: 37538176
Free PMC article.